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Background
Hypertension is an important modifiable risk factor for
coronary heart disease, congestive heart failure, stroke,
end-stage renal disease, and peripheral vascular disease.
Many of the molecular mechanisms and genetic factors
underlying the development of the most common forms
of human hypertension remain to be defined. Nitric oxide
(NO) and one of its primary targets, the cyclic guanosine
monophosphate (cGMP) generating enzyme soluble gua-
nylate cyclase (sGC), play an essential role in regulating
blood pressure, in part by by modulating relaxation of vas-
cular smooth muscle.
Results
Male mice deficient in the a1 subunit of soluble guanylate
cyclase (sGCa1-/- mice) are prone to hypertension in
some, but not all, mouse strains, suggesting that additional
genetic factors contribute to the onset of hypertension
associated with sGCa1-deficiency. Using linkage analyses,
we discovered quantitative trait loci (QTL) that were
linked to mean arterial pressure (MAP) in sGCa1-/- mice.
One locus is syntenic with previously identified blood
pressure–related QTLs in the human and rat genome and
contains the genes coding for renin. Hypertension in
sGCa1-/- mice was associated with increased activity of
the renin-angiotensin-aldosterone system (RAAS) and
RAAS inhibition normalized MAP and improved endothe-
lium-dependent vasorelaxation in sGCa1-/- mice.
Conclusion
These data identify the RAAS as a blood pressure–
modifying mechanism in a setting of impaired NO/cGMP
signaling [1].
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